On January 19th, MassBio, at the request of the Joint Committee on Healthcare Financing, testified at the first in a series of informational sessions intended to provide legislators, stakeholders, and the public with a comprehensive understanding of issues of drug cost and value.
The session, held at in Springfield, convened speakers from the life sciences, healthcare, payer, provider and patient communities.
MassBio participated in the opening panel alongside representatives from PhRMA and the Pioneer Valley Life Sciences Institute and the University of Massachusetts.
The Committee is planning additional sessions. MassBio looks forward to continued participation in this effort.